Cargando…

Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies

A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Bréard, Emmanuel, Lara, Estelle, Comtet, Loïc, Viarouge, Cyril, Doceul, Virginie, Desprat, Alexandra, Vitour, Damien, Pozzi, Nathalie, Cay, Ann Brigitte, De Regge, Nick, Pourquier, Philippe, Schirrmeier, Horst, Hoffmann, Bernd, Beer, Martin, Sailleau, Corinne, Zientara, Stéphan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546048/
https://www.ncbi.nlm.nih.gov/pubmed/23335964
http://dx.doi.org/10.1371/journal.pone.0053446
_version_ 1782255990056419328
author Bréard, Emmanuel
Lara, Estelle
Comtet, Loïc
Viarouge, Cyril
Doceul, Virginie
Desprat, Alexandra
Vitour, Damien
Pozzi, Nathalie
Cay, Ann Brigitte
De Regge, Nick
Pourquier, Philippe
Schirrmeier, Horst
Hoffmann, Bernd
Beer, Martin
Sailleau, Corinne
Zientara, Stéphan
author_facet Bréard, Emmanuel
Lara, Estelle
Comtet, Loïc
Viarouge, Cyril
Doceul, Virginie
Desprat, Alexandra
Vitour, Damien
Pozzi, Nathalie
Cay, Ann Brigitte
De Regge, Nick
Pourquier, Philippe
Schirrmeier, Horst
Hoffmann, Bernd
Beer, Martin
Sailleau, Corinne
Zientara, Stéphan
author_sort Bréard, Emmanuel
collection PubMed
description A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n = 1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe.
format Online
Article
Text
id pubmed-3546048
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35460482013-01-18 Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies Bréard, Emmanuel Lara, Estelle Comtet, Loïc Viarouge, Cyril Doceul, Virginie Desprat, Alexandra Vitour, Damien Pozzi, Nathalie Cay, Ann Brigitte De Regge, Nick Pourquier, Philippe Schirrmeier, Horst Hoffmann, Bernd Beer, Martin Sailleau, Corinne Zientara, Stéphan PLoS One Research Article A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n = 1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe. Public Library of Science 2013-01-15 /pmc/articles/PMC3546048/ /pubmed/23335964 http://dx.doi.org/10.1371/journal.pone.0053446 Text en © 2013 Bréard et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bréard, Emmanuel
Lara, Estelle
Comtet, Loïc
Viarouge, Cyril
Doceul, Virginie
Desprat, Alexandra
Vitour, Damien
Pozzi, Nathalie
Cay, Ann Brigitte
De Regge, Nick
Pourquier, Philippe
Schirrmeier, Horst
Hoffmann, Bernd
Beer, Martin
Sailleau, Corinne
Zientara, Stéphan
Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title_full Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title_fullStr Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title_full_unstemmed Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title_short Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies
title_sort validation of a commercially available indirect elisa using a nucleocapside recombinant protein for detection of schmallenberg virus antibodies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546048/
https://www.ncbi.nlm.nih.gov/pubmed/23335964
http://dx.doi.org/10.1371/journal.pone.0053446
work_keys_str_mv AT breardemmanuel validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT laraestelle validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT comtetloic validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT viarougecyril validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT doceulvirginie validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT despratalexandra validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT vitourdamien validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT pozzinathalie validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT cayannbrigitte validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT dereggenick validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT pourquierphilippe validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT schirrmeierhorst validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT hoffmannbernd validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT beermartin validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT sailleaucorinne validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies
AT zientarastephan validationofacommerciallyavailableindirectelisausinganucleocapsiderecombinantproteinfordetectionofschmallenbergvirusantibodies